7 October 2021 – Ansell Limited (ASX:ANN) announces it will invest ~$80m over the next three years to build a new manufacturing facility in Tamil Nadu, India. The facility will have the capability to produce a wide range of products, with an initial focus on surgical and life science gloves for the Indian domestic market and for export. Ansell’s surgical and life sciences businesses are core to the company’s differentiated growth strategy.
The facility will be designed and built in line with Indian Green Building Council criteria to minimise water and energy use, maximise renewable energy use and meet zero liquid discharge and as such it will set a new benchmark at Ansell for sustainable manufacturing. It will create important diversification in Ansell’s manufacturing footprint and create significant additional capacity to supply our industry leading portfolio of surgical and life science protection solutions to customers globally.
“Ansell’s surgical and life sciences businesses have delivered strong growth, and we see significant customer interest in our portfolio of solutions. This investment in India demonstrates our long-term commitment to growing these businesses and satisfying the needs of our customers,” said Neil Salmon, Chief Executive Officer and Managing Director.
“We selected India for Ansell’s first greenfield investment in many years because of the importance of the Indian market to our emerging market growth strategy and because we are confident our Indian facility will be a high quality and competitive production location for our global customers. We are building a facility with the option of significant future expansion capability across a wide range of Ansell products and so able to support our growth strategy over many years,” added Darryl Nazareth, President of Healthcare Global Business Unit.
This announcement was authorised for release by the Board of Directors of Ansell Limited.